Eversept Partners’s Audentes Therapeutics, Inc BOLD Stock Holding History

Eversept Partners’s Portfolio BOLD Stock Details BOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-305,726	Closed	-$18.3M	–	85
2019 Q4	$18.3M	Buy	305,726 +52,000	+20%	+$1.95M	3.23%	11
2019 Q3	$7.13M	Buy	253,726 +94,200	+59%	+$3.21M	2.21%	13
2019 Q2	$6.04M	Buy	+159,526	New	+$6.13M	1.69%	17

Eversept Partners's BOLD Position: Q1 2020 in Review

Eversept Partners sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 305,726 shares — an estimated $18.3M sold.

Eversept Partners first reported a position in BOLD in Q2 2019 and held it in 3 quarters. The position peaked at $18.3M in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

Eversept Partners reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
Eversept Partners sold 305,726 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $18.3M.
Eversept Partners first reported a position in Audentes Therapeutics, Inc in Q2 2019 and held it in 3 quarters.
Eversept Partners's Audentes Therapeutics, Inc position peaked at $18.3M in Q4 2019.
0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on Eversept Partners's 13F filing for Q1 2020, filed 13 May 2020.